Hi, DEB.
"They were all very kind, but ignored any comments
we had about the relationship between my symptoms
and 13 years of statin use."
--DEB
I think that's a little disturbing. Wonder if they have heard ALL ABOUT the statin issue, have checked into it and reject it; or if they are just unaware of it? They may be in a professional bubble where it has never been seriously discussed. You might want to see if you can get a sense where they are on the matter. It could make a difference.
Is it possible that the layman can get ahead of the doctors and specialists? Sure. I contend we're all proof of it with the doctors, and catching up fast or maybe passing some of the specialists? But here may be some definitive proof either will recognize as such (while probably not admit it). It is a study and finding from this year on improved diagnosis of ALS. Where from? You guessed it -- Wikipedia! (Yes, I know I mentioned this before, but here is again anyway in more complete form, I think.)
Here's the hyperlink to their full presentation on ALS, but right below it is their summary of the research on the new diagnostic test, and then right below that is the summary by the researchers themselves about their own research (i.e., "Footnote 10" reprinted)
*http://en.wikipedia.org/wiki/Amyotrophic_lateral_sclerosis
Wikipidia:
"Recently researchers from Mount Sinai School of Medicine identified three proteins that are found in significantly lower concentration in the cerebral spinal fluid of patients with ALS than in healthy individuals. This finding was published in the February 2006 issue of Neurology. Evaluating the levels of these three proteins proved 95% accurate for diagnosing ALS. These are the first biomarkers for this disease and may be first tools for confirming diagnosis of ALS. With current methods, the average time from onset of symptoms to diagnosis is around 12 months. Improved diagnostic markers may provide a means of early diagnosis, allowing patients to receive relief from symptoms years earlier. [10]"
Here's Footnote 10:
10. Pasinetti G, Ungar L, Lange D, Yemul S, Deng H, Yuan X, Brown R, Cudkowicz M, Newhall K, Peskind E, Marcus S, Ho L (2006). "Identification of potential CSF biomarkers in ALS". Neurology 66 [8]: 1218-22. PMID 16481598.
Heres the PubMed hyperlink from the footnote (but right reprinted below) BTW, CFS is short for Cerebral Spinal Fluid:
*http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16481598
Identification of potential CSF biomarkers in ALS. (2006 Apr 25;66[8]:1218-22. Epub 2006 Feb 15.)
Pasinetti GM, Ungar LH, Lange DJ, Yemul S, Deng H, Yuan X, Brown RH, Cudkowicz ME, Newhall K, Peskind E, Marcus S, Ho L.
Geriatric Research, Education, and Clinical Center, Bronx Veterans Affairs Medical Center, Bronx, NY, USA.
*giulio.pasinetti@mssm.edu
BACKGROUND: The clinical diagnosis of ALS is based entirely on clinical features. Identification of biomarkers for ALS would be important for diagnosis and might also provide clues to pathogenesis.
OBJECTIVE: To determine if there is a specific protein profile in the CSF that distinguishes patients with ALS from those with purely motor peripheral neuropathy (PN) and healthy control subjects.
METHODS: CSF obtained from patients with ALS, disease controls (patients with other neurologic disorders), and normal controls were analyzed using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomics technique. Biomarker sensitivity and specificity was calculated with receiver operating characteristic curve methodology. ALS biomarkers were purified and sequence identified by mass spectrometry-directed peptide sequencing.
RESULTS: In initial proteomic discovery studies, three protein species (4.8-, 6.7-, and 13.4-kDa) that were significantly lower in concentration in the CSF from patients with ALS (n = 36) than in normal controls (n = 21) were identified. A combination of three protein species (the "three-protein" model) correctly identified patients with ALS with 95% accuracy, 91% sensitivity, and 97% specificity from the controls. Independent validation studies using separate cohorts of ALS (n = 13), healthy control (n = 25), and PN (n = 7) subjects confirmed the ability of the three CSF protein species to separate patients with ALS from other diseases. Protein sequence analysis identified the 13.4-kDa protein species as cystatin C and the 4.8-kDa protein species as a peptic fragment of the neurosecretory protein VGF.
CONCLUSION: Additional application of a "three-protein" biomarker model to current diagnostic criteria may provide an objective biomarker pattern to help identify patients with ALS.
"I did ask about exercise. He suggested that since
my arms are weak, that I let my everyday chores
be my "exercise" for them, but to continue
exercising my legs as I have been as they are still
strong."
--DEB
For now, that is what I have decided to do on both counts.
" I just hope it stops progressing."
--DEB
Could you characterize/describe your rate of progression over some period of time to current? Mine is stable to slightly increasing in both arms.
Stephen Hawking has had his ALS for decades. So it may not always be the death sentence as it use to be considered. That, provided that you even have "ALS" which I still believe you do not. However, an actual diagnosis, or not, may be a difference with little distinction if the mechanism for degeneration is similar or identical, just much slower, as may be the case with this manifestation of chronic statin toxicity. In fact, you (indeed "we") may have similar versions of whatever Hawking actually has -- a slow version? But here's an upside for you perhaps. You are in relatively good condition and becoming a known case to practitioners, you may be more readily identified and qualified for hard to get in on clinical trials ("guinea pig status") when effective treatments arrive. Medical knowledge is increasing exponentially these days -- no joke (and will do so even faster once bush is gone assuming he is not replaced by an equal, if that could be possible). Fixing ALS has got to be on some priority lists.
You may want to take a copy of the study just to see if they have ever heard of it (watch their eyes as they are scanning it over, if you can). If not, I too would be more inclined to consider the advice given by eml256 in this thread (I am sure she intended it to go in this thread):
http://www.spacedoc.net/board/viewtopic ... 8ee18#4496
Keep us posted. Your vitamin list looked a lot like mine except for slight differences in doses here and there and the following three which I do not currently take but will probably start, and the last two which I do not know anything about but may look into.
TMG 500 mg 3 x per day
Pantothenic Acid 250 mg 3 x per day
NADH 5 mg per day
Juice Plus Multi
Chelated Calcium and Magnesium
And good luck!
Biologist